Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H18N2O |
| Molecular Weight | 278.3483 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N1C(=O)N=C(C2=CC=CC=C2)C3=C1C=C(C)C=C3
InChI
InChIKey=JTIGKVIOEQASGT-UHFFFAOYSA-N
InChI=1S/C18H18N2O/c1-12(2)20-16-11-13(3)9-10-15(16)17(19-18(20)21)14-7-5-4-6-8-14/h4-12H,1-3H3
| Molecular Formula | C18H18N2O |
| Molecular Weight | 278.3483 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Proquazon, a non-steroidal anti-inflammatory agent that was studied to use in the management of rheumatoid arthritis and osteoarthritis. The biochemical mechanism of action of proquazon via the inhibition of the core protein synthesis of proteoglycans and the secondary biosynthesis of the glucosamine.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0030166 Sources: https://www.ncbi.nlm.nih.gov/pubmed/442844 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | 2010-12 |
|
| High-performance liquid chromatographic determination of proquazone and its m-hydroxy metabolite in spiked human plasma and urine. | 2007-09-01 |
|
| A peripatetic pediatrician's journey into pediatric rheumatology: Part II. | 2007-06-21 |
|
| Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution. | 2004-12-09 |
|
| Effects of cyclooxygenase inhibitors on nitric oxide production and survival in a mice model of sepsis. | 2003-07 |
|
| Effects of inflammation and antiinflammatory treatment on serum trace elements concentrations. | 2003 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3297621
proquazone 300 to 900 mg/day
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:32:44 GMT 2025
by
admin
on
Mon Mar 31 18:32:44 GMT 2025
|
| Record UNII |
42VPJ2980S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
||
|
WHO-ATC |
M01AX13
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
||
|
WHO-VATC |
QM01AX13
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
42VPJ2980S
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
PROQUAZONE
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
22760-18-5
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
3176
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
SUB10127MIG
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
2311
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
C011385
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
100000080810
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
C73093
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
31508
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
DTXSID4021210
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
245-203-7
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
m9254
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | Merck Index | ||
|
42VPJ2980S
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
CHEMBL268501
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY | |||
|
DB13649
Created by
admin on Mon Mar 31 18:32:44 GMT 2025 , Edited by admin on Mon Mar 31 18:32:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |